Trial Details
AuthorisedBasic Information
| Clinical ID | c3169 |
|---|---|
| Identifier | EUCTR2012-004214-34-IT |
| Trial Title | Comparison of efficacy and acceptability of bisacodil and PEG-CS 2 L and PEG 4 L in patients with chronic inflammatory bowel disease: single center, randomized, single blind, parallel groups study |
| Trial URL | Visit Original Page |
Study Information
| Study Results | No results available |
|---|---|
| Conditions | IBD patients undergoing a colonoscopy. MedDRA version: 15.0_Level: LLT_Classification code 10045282_Term: UC_System Organ Class: 100000004856_;Therapeutic area: Diseases [C] - Digestive System Diseases [C06] |
| Interventions | Trade Name: LOVOLDYL*30CPR RIV 5MG Pharmaceutical Form: Coated tablet Other descriptive name: bisacodyl Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 5- Trade Name: SELG*OS POLV 4BUST 70G 1LT Pharmaceutical Form: Oral powder Other descriptive name: macrogol Concentration unit: g gram(s) Concentration type: equal Concentration number: 70- |
Participant Information
| Sponsor | AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) |
|---|---|
| City | - |
| Country/Region | Italy |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | - |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | Not Available |
Time Information
| Start Date | 2025-04-24 |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |